Drugs / RO6953958
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04475848 | Jul 2020 → Feb 2022 | autism | Hoffmann-La Roche | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RO6953958 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04475848 ↗ |
| Route | Oral | “following oral administration” NCT04475848 ↗ |